NEW YORK (360Dx) — RenalytixAI said today that it has partnered with the University Medical Center Groningen (UMCG) in the Netherlands to evaluate its KidneyIntelX kidney disease test in a 3,500-patient clinical study.
NEW YORK (360Dx) — RenalytixAI said today that it has partnered with the University Medical Center Groningen (UMCG) in the Netherlands to evaluate its KidneyIntelX kidney disease test in a 3,500-patient clinical study.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.